End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.46 CNY | -0.92% | +4.46% | +7.04% |
Apr. 24 | Runben Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 1.35B 187M | Sales 2025 * | 1.72B 238M | Capitalization | 7.87B 1.09B |
---|---|---|---|---|---|
Net income 2024 * | 287M 39.72M | Net income 2025 * | 360M 49.82M | EV / Sales 2024 * | 5.84 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 4.58 x |
P/E ratio 2024 * |
27.4
x | P/E ratio 2025 * |
21.9
x | Employees | 788 |
Yield 2024 * |
0.99% | Yield 2025 * |
1.23% | Free-Float | 15.26% |
1 day | -0.92% | ||
1 week | +4.46% | ||
Current month | +4.46% | ||
1 month | +23.95% | ||
3 months | +42.67% | ||
6 months | +7.22% | ||
Current year | +7.04% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 19.46 | -0.92% | 1,991,752 |
24-05-07 | 19.64 | +0.05% | 3,685,159 |
24-05-06 | 19.63 | +5.37% | 3,987,803 |
24-04-30 | 18.63 | +0.81% | 2,551,068 |
End-of-day quote Shanghai S.E., May 07, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 603193 Stock